NOVAVAX Trademark

Trademark Overview

On Thursday, September 2, 2021, a trademark application was filed for NOVAVAX with the United States Patent and Trademark Office. The USPTO has given the NOVAVAX trademark a serial number of 97008364. The federal status of this trademark filing is STATEMENT OF USE - TO EXAMINER as of Wednesday, June 12, 2024. This trademark is owned by Novavax, Inc.. The NOVAVAX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of infectious diseases; vaccines; adjuvants for medical purposes
novavax

General Information

Serial Number97008364
Word MarkNOVAVAX
Filing DateThursday, September 2, 2021
Status748 - STATEMENT OF USE - TO EXAMINER
Status DateWednesday, June 12, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, September 13, 2022

Trademark Statements

Description of MarkThe mark consists of the word "NOVAVAX" to the left of a circle made up of smaller different shaped circles.
Goods and ServicesPharmaceutical preparations for the treatment of infectious diseases; vaccines; adjuvants for medical purposes
Pseudo MarkNOVA VAX; NOVA V AX

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, October 15, 2021
Primary Code005
First Use Anywhere DateSunday, October 15, 2023
First Use In Commerce DateSunday, October 15, 2023

Trademark Owner History

Party NameNovavax, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGaithersburg, MD 20878
Party NameNovavax, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGaithersburg, MD 20878

Trademark Events

Event DateEvent Description
Monday, September 6, 2021NEW APPLICATION ENTERED
Friday, October 15, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, October 16, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, March 31, 2022ASSIGNED TO EXAMINER
Thursday, March 31, 2022NON-FINAL ACTION WRITTEN
Thursday, March 31, 2022NON-FINAL ACTION E-MAILED
Thursday, March 31, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, July 29, 2022EXAMINERS AMENDMENT -WRITTEN
Friday, July 29, 2022EXAMINERS AMENDMENT E-MAILED
Friday, July 29, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, July 29, 2022EXAMINER'S AMENDMENT ENTERED
Sunday, August 7, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 24, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 13, 2022PUBLISHED FOR OPPOSITION
Tuesday, September 13, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 8, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, March 29, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, March 29, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, March 29, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, March 29, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 29, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, April 13, 2023SOU TEAS EXTENSION RECEIVED
Thursday, April 13, 2023SOU EXTENSION 1 FILED
Thursday, April 13, 2023SOU EXTENSION 1 GRANTED
Saturday, April 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 10, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, October 10, 2023SOU EXTENSION 2 FILED
Tuesday, October 10, 2023SOU EXTENSION 2 GRANTED
Thursday, October 12, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 4, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, March 4, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, March 4, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, May 8, 2024USE AMENDMENT FILED
Wednesday, May 8, 2024TEAS STATEMENT OF USE RECEIVED
Wednesday, June 12, 2024STATEMENT OF USE PROCESSING COMPLETE
Wednesday, June 12, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL

Related Keywords

novavax adjuvants medical purposes vaccines diseases preparations treatment infectious pharmaceutical